Vericel Corporation: Advanced cell therapy; marketing MACI (cartilage repair) and Epicel (skin replacementt) in TAMs of $2b+. Recently acquired US commercial rights for NexoBrid.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
USA
Clinical Stage
Marketed
Disease Space
Dermatology, Tools
Finance
Revenues
Industry
Biotechnology, Medical Device, Medical Technology
Listing
Public, USA
Market Cap
500MM +
Therapeutic Modalities
Cell Therapy
Website:
Address:
64 Sidney Street
Cambridge, MA 02139
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Hamptons CEO Roundtable 2019

Bridgehampton, August 15, 2019

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.